Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.78 |
| ▸ | BLM | P54132 | 1/20 | 0.78 |
| ▸ | CASP7 | P55210 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | XDH | P47989 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.57 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | P4HB | P07237 | 1/20 | 0.55 |
| ▸ | F3 | P13726 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8459973 | 1.00 | MAPT (0.78) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL16051996 | 0.93 | CYP1A2 (0.70) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL16051995 | 0.93 | CYP1A2 (0.70) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL10070198 | 0.89 | MAPT (0.68) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL16052183 | 0.89 | CYP1B1 (0.71) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL23082321 | 0.89 | CYP1A2 (0.64) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL28481451 | 0.89 | MAPT (0.68) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL10070189 | 0.89 | CYP1B1 (0.71) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL23082314 | 0.89 | CYP1A2 (0.64) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 | |
| SCHEMBL8458037 | 0.88 | SRD5A2 (0.69) | MAPTSMN1; SMN2TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118445349-A | Implementation method for quickly constructing operator visualization model by web terminal | 北京中科锦智数字技术有限公司 | 2024-08-06 | — | — | CN | claimed |
| US-20260144857-A1 | SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260049215-A1 | ASPHALT COMPOSITION AND PRODUCTION METHOD THEREFOR | RESONAC CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-4644488-A1 | ASPHALT COMPOSITION AND PRODUCTION METHOD THEREFOR | Resonac Corporation (JP) | 2025-11-05 | — | — | EP | disclosed |
| EP-4360617-B1 | FORMULATION COMPRISING ESTER QUATS BASED ON TRIALKANOLAMINES | EVONIK OPERATIONS GMBH (DE) | 2025-07-02 | — | — | EP | disclosed |
| CN-113552768-B | Photosensitive coloring composition, color filter and image display device | 爱天思株式会社 | 2025-06-17 | — | — | CN | disclosed |
| EP-4563663-A1 | ASPHALT EMULSION COMPOSITION AND METHOD FOR PRODUCING SAME | Resonac Corporation (JP) | 2025-06-04 | — | — | EP | disclosed |
| CN-119677814-A | Asphalt composition and method for producing same | 株式会社力森诺科 | 2025-03-21 | — | — | CN | disclosed |
| CN-119604583-A | Asphalt emulsion composition and method for producing same | 株式会社力森诺科 | 2025-03-11 | — | — | CN | disclosed |
| CN-119372924-A | Preparation method of particle decoration electrostatic spinning anti-corrosion coating with corrosion early warning and self-repairing functions | 中国海洋大学 | 2025-01-28 | — | — | CN | disclosed |
| WO-2022172645-A1 | COMPOUND IN WHICH POLYGLYCEROL, FATTY ACID, AND DICARBOXYLIC ACID HAVE BEEN ESTERIFIED | 太陽化学株式会社 | 2022-08-18 | — | — | WO | disclosed |
| CN-110003126-B | Preparation method of ultraviolet absorbent Tinuvin 928 | 威海金威化学工业有限责任公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20220133846-A1 | NOVEL ANTIMICROBIAL COMPOUND AND USES THEREOF | FRAUNHOFER USA INC. (US) | 2022-05-05 | — | — | US | disclosed |
| EP-3991794-A1 | EXTERNAL PREPARATION FOR SKIN | Kao Corporation (JP) | 2022-05-04 | — | — | EP | disclosed |
| WO-2022085432-A1 | SOLID SHAMPOO | 花王株式会社 | 2022-04-28 | — | — | WO | disclosed |
| EP-3957659-A1 | FUNCTIONALIZED POLYMERS | Evonik Operations GmbH (DE) | 2022-02-23 | — | — | EP | disclosed |
| WO-1999048529-A1 | RETINOID-GLITAZONE COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 1999-09-30 | — | — | WO | disclosed |
| EP-0808159-A1 | USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024344-A1 | USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| US-5489611-A | ADMINISTERING A RETINOID COMPOUND | WARNER-LAMBERT COMPANY (US) | 1996-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144857-A1 | SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF | HLA-DRB1, SPOP, STXBP1 | MAPT 1642/4885SMN1; SMN2 805/4885TP53 957/4885 |
| US-20260049215-A1 | ASPHALT COMPOSITION AND PRODUCTION METHOD THEREFOR | LCAT, CETP, SOAT1 | MAPT 19/4885SMN1; SMN2 2222/4885TP53 2932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.